Cargando…

Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19

The susceptibility and the severity of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with hyperandrogenism, obesity, and preexisting pulmonary, metabolic, renal, and cardiac conditions. Polycystic ovary syndrome (PCOS), the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezq, Samar, Huffman, Alexandra M., Basnet, Jelina, Yanes Cardozo, Licy L., Romero, Damian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470275/ https://www.ncbi.nlm.nih.gov/pubmed/34575910 http://dx.doi.org/10.3390/ijms22189746

Ejemplares similares

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

Hepatic Dysregulation of Bile Acid Homeostasis in Hyperandrogenemic Female Mouse Model of Polycystic Ovary Syndrome
por: Huffman, Alexandra M, et al.
Publicado: (2021)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
por: Huffman, Alexandra M., et al.
Publicado: (2021)

MicroRNA-21 Modulates White Adipose Tissue Browning and Altered Thermogenesis in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2021)

OR35-01 Colonic Mitochondrial Dysfunction and Sub-acute Gastrointestinal Inflammation in Two Hyperandrogenemic Rodent Models of PCOS
por: Hoang, Ngoc, et al.
Publicado: (2023)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
por: Pruett, Jacob E, et al.
Publicado: (2021)

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors
por: Pruett, Jacob E., et al.
Publicado: (2023)

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021)

Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
por: Romero, Damian G, et al.
Publicado: (2016)

Novel biomarkers of childhood and adolescent obesity
por: Yanes Cardozo, Licy L., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race Against the Clock
por: Huffman, Alexandra M, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women
por: Pruett, Jacob E, et al.
Publicado: (2022)

PMON225 Androgen excess in pre-menopausal women due to Granulosa Cell tumor: A case report.
por: Kaval, Roopitha, et al.
Publicado: (2022)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Cardiovascular and Metabolic Consequences of Testosterone Supplements in Young and Old Male Spontaneously Hypertensive Rats: Implications for Testosterone Supplements in Men
por: Dalmasso, Carolina, et al.
Publicado: (2017)

SAT-361 Familial Hypocalciuric Hypercalcemia Type 3: AP2S1 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2020)

In an Ovine Model of Polycystic Ovary Syndrome (PCOS) Prenatal Androgens Suppress Female Fetal Renal Gluconeogenesis
por: Connolly, Fiona, et al.
Publicado: (2015)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats
por: Zhai, Hua-Ling, et al.
Publicado: (2012)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition
por: Pruett, Jacob E., et al.
Publicado: (2022)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome
por: Tian, Lifeng, et al.
Publicado: (2021)

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
por: Ding, Haigang, et al.
Publicado: (2021)

Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2022)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eretfks254kvpg5r3dcvdbtnl9